Search

Your search keyword '"Gladman, Dafna D"' showing total 2,741 results

Search Constraints

Start Over You searched for: Author "Gladman, Dafna D" Remove constraint Author: "Gladman, Dafna D"
2,741 results on '"Gladman, Dafna D"'

Search Results

201. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

204. Contributors

207. 25851 Efficacy of secukinumab in managing axial manifestations and nail psoriasis in patients with psoriatic arthritis: Results from the MAXIMISE trial

212. Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria

214. ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients

215. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

218. sj-docx-1-tab-10.1177_1759720X211057975 ��� Supplemental material for Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

219. sj-docx-2-tab-10.1177_1759720X211057975 ��� Supplemental material for Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

220. Table S1 - Supplemental material for Assessment of the Toronto Psoriatic Arthritis Screen 2 as a Screening Tool for Psoriasis

221. Additional file 1 of Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib

222. Supplementary Material 1 - Supplemental material for Assessment of the Toronto Psoriatic Arthritis Screen 2 as a Screening Tool for Psoriasis

223. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies

224. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.

225. Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients With Psoriatic Arthritis.

226. Medium Versus High Initial Prednisone Dose for Remission Induction in Lupus Nephritis: A Propensity Score–Matched Analysis.

227. Incidence of and Risk Factors for Heart Failure in Patients With Psoriatic Disease: A Cohort Study.

228. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

235. The future

236. Therapeutics

239. Epidemiology

240. Prognosis

244. Co-morbidities

245. Surgery

250. The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?

Catalog

Books, media, physical & digital resources